Rg1 improves NPC proliferation, reduces apoptosis, and enhances aggrecan and type II collagen (Col2α1) expression by inhibiting the Wnt/β-catenin signaling pathway (Yu et al., 2020). The gene discussed is PPP1R3A; the disease is nasopharyngeal carcinoma.